LogoLogo
  • Technology
  • Events
  • Company
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
SearchSearchFind a clinicFind a clinic
Search
Products
AestheticsVision
Technology
Resources
WebinarsClinical PublicationsPhysician TestimonialsNewsFAQs
Events
Company
Find a clinic
Logo

Discover Tixel® powered by TMA® technology. Revolutionary fractional skin resurfacing with maximum safety, minimal side effects. Quick, effective treatments for aesthetic and dry eye applications.

Support
  • Get Support
  • Request a Demo
Product
  • Aesthetics
  • Vision
Company
  • About the Company
  • Contact Us
  • Events
Resources
  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials
Legal
  • Intellectual Property
  • Counterfeit Devices Warning
Regulation
  • Quality Assurance
  • Regulatory Updates

Product

  • Aesthetics
  • Vision

Company

  • About the Company
  • Contact Us
  • Events

Resources

  • News
  • Webinars
  • Clinical Publications
  • FAQs
  • Testimonials

Support

  • Get Support
  • Request a Demo

Legal

  • Intellectual Property
  • Counterfeit Devices Warning

Regulation

  • Quality Assurance
  • Regulatory Updates

Newsletter

Stay updated with our latest Tixel news.

© 2026 Tixel®, Novoxel®, and TMA®. All rights reserved.

Privacy policyCookie preferences
  1. Clinical Publications
  2. /
  3. The Toxic Edge: A Novel Treatment for Refractory Erythema and Flushing of Rosacea
Peer-reviewed paper

The Toxic Edge: A Novel Treatment for Refractory Erythema and Flushing of Rosacea

Authors
Or Friedman, Amir Koren, Roni Niv, Joseph N. Mehrabi, Ofir Artzi
Journal
PubMed
Published
October 12, 2018
View publication

Opens in a new tab.

← View all Clinical Publications